6533b7d0fe1ef96bd125a954

RESEARCH PRODUCT

The risk of Second Primary Cancers (SPCS) in patients with Splenic Marginal Zone Lymphoma (SMZL)

Stefano De CantisAnna Maria TaorminaIannitto E.

subject

http://hdl.handle.net/10447/25631